Published in Chem Commun (Camb) on January 21, 2003
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis (2009) 22.98
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.59
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52
Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis (2011) 5.58
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics (2004) 3.71
Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis (2004) 3.35
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) (2010) 2.67
Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2005) 2.28
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics (2002) 2.08
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J (2013) 1.90
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis (2009) 1.83
Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics (2010) 1.77
Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J (2007) 1.65
Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J (2013) 1.52
Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J (2004) 1.52
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis (2012) 1.49
Best in class: a good principle for antibiotic usage to limit resistance development? J Antimicrob Chemother (2007) 1.44
Management of complicated shunt infections: a clinical report. J Neurosurg Pediatr (2008) 1.42
Staghorn calculus endotoxin expression in sepsis. Urology (2002) 1.41
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J (2007) 1.41
What is the appropriate treatment course for bacterial arthritis in children? Clin Infect Dis (2009) 1.39
Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol (2010) 1.36
Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J (2002) 1.28
The use of systemic and topical fluoroquinolones. Pediatrics (2011) 1.25
Evaluation of acoustical conditions for speech communication in working elementary school classrooms. J Acoust Soc Am (2008) 1.22
Bis(4-methylbenzylammonium) tetrachloridozincate: a new noncentrosymmetric structure characterized by 13C CP-MAS NMR spectroscopy. Acta Crystallogr C (2011) 1.17
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis (2014) 1.17
Streptococcus pneumoniae infections in the neonate. Pediatrics (2003) 1.14
Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia. Clin Infect Dis (2008) 1.11
Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J (2002) 1.09
Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002. Ann Clin Microbiol Antimicrob (2004) 1.07
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J (2010) 1.04
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother (2006) 1.00
Defining pneumonia in critically ill infants and children. Pediatr Crit Care Med (2005) 0.97
Quality of care among Aboriginal hemodialysis patients. Clin J Am Soc Nephrol (2005) 0.96
Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol (2011) 0.95
Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections. Pediatr Infect Dis J (2011) 0.93
Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza. Curr Med Res Opin (2007) 0.93
Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age. Clin Infect Dis (2010) 0.91
Levofloxacin pharmacokinetics in children. J Clin Pharmacol (2005) 0.91
Endotoxin content in renal calculi. J Urol (2003) 0.89
Pediatric acute hemorrhagic leukoencephalitis: report of a surviving patient and review. Clin Infect Dis (2002) 0.87
Genetic structure of community acquired methicillin-resistant Staphylococcus aureus USA300. BMC Genomics (2012) 0.87
Pneumococcal endocarditis in children. Clin Infect Dis (2004) 0.86
Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol (2013) 0.86
In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides. Antimicrob Agents Chemother (2003) 0.85
Vancomycin monitoring in children using bayesian estimation. Ther Drug Monit (2014) 0.84
Pharmacokinetics of gatifloxacin in infants and children. Antimicrob Agents Chemother (2005) 0.83
Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents. Antimicrob Agents Chemother (2007) 0.83
An artificial neural network approach for predicting architectural speech security. J Acoust Soc Am (2005) 0.82
Measures for assessing architectural speech security (privacy) of closed offices and meeting rooms. J Acoust Soc Am (2004) 0.81
Pediatric anthrax clinical management. Pediatrics (2014) 0.81
Prediction of neurologic sequelae in childhood tuberculous meningitis: a review of 20 cases and proposal of a novel scoring system. Pediatr Infect Dis J (2005) 0.81
Linezolid-associated peripheral and optic neuropathy in children. Pediatrics (2011) 0.81
Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics. Semin Pediatr Infect Dis (2004) 0.80
A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Pediatr Infect Dis J (2016) 0.79
Exchange blood transfusion in the management of severe pertussis in young infants. Pediatr Infect Dis J (2013) 0.79
Bone marrow-derived progenitor cells contribute to lung remodelling after myocardial infarction. Cardiovasc Pathol (2007) 0.78
Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia. Pediatr Infect Dis J (2015) 0.78
A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis. J Pediatr Orthop (2009) 0.78
Population pharmacokinetic model for gatifloxacin in pediatric patients. Antimicrob Agents Chemother (2007) 0.78
Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days. Pediatr Neurosurg (2008) 0.78
Optimizing therapy with antibacterial agents: use of pharmacokinetic-pharmacodynamic principles in pediatrics. Paediatr Drugs (2007) 0.77
Polyoxometalate grafting onto silica: stability diagrams of H3PMo12O40 on {001}, {101}, and {111} β-cristobalite surfaces analyzed by DFT. Phys Chem Chem Phys (2011) 0.77
A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia. Pediatr Infect Dis J (2016) 0.77
Pediatric anthrax clinical management: executive summary. Pediatrics (2014) 0.77
A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection. Pediatr Infect Dis J (2016) 0.76
Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure. Pediatr Infect Dis J (2016) 0.76
1-(2,5-Dimethyl-phen-yl)piperazine-1,4-diium tetra-chloridozincate monohydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age. Pediatr Infect Dis J (2017) 0.75
Bis(2-amino-1,3-benzothia-zol-3-ium) tetra-chloridozincate(II). Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr Infect Dis J (2003) 0.75
General method of preparation of mesoporous M/Si3N4 nano-composites via a non-aqueous sol-gel route. Chem Commun (Camb) (2005) 0.75
Using listening difficulty ratings of conditions for speech communication in rooms. J Acoust Soc Am (2005) 0.75
Formation of a covalent bond between a polyoxometalate and silica covered by SiH moieties. Inorg Chem (2014) 0.75
Characterization of silica-supported dodecatungstic heteropolyacids as a function of their dehydroxylation temperature. Dalton Trans (2009) 0.75
Editor's note. Pediatr Infect Dis J (2013) 0.75
Guidelines for the selection of antibacterial therapy in children. Pediatr Clin North Am (2005) 0.75
Catalytic oxidation of light alkanes (C1-C4) by heteropoly compounds. Chem Rev (2013) 0.75
Grafting reaction of organotin complexes on silica catalyzed by tungstic heteropolyacids. Inorg Chem (2009) 0.75
Reactivity of anhydrous keggin-type heteropolyacids with alkylsilanes: synthesis and characterization. Inorg Chem (2010) 0.75
An Observational Study of Severe Pertussis in 100 Infants ≤ 120 Days of Age. Pediatr Infect Dis J (2017) 0.75
Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients. Pediatr Crit Care Med (2017) 0.75
Independent control of adhesive and bulk properties of hybrid silica coatings on polycarbonate. ACS Appl Mater Interfaces (2013) 0.75
Transmission of meropenem in breast milk. Pediatr Infect Dis J (2012) 0.75